Engineered Immune Cells May Be Able to Tame Inflammation
By Sarah C.P. Williams on December 05, 2024
Immune cells that are designed to soothe could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions. configuration options Engineered Receptors Help the Immune System Home in on Cancer
By Sarah C.P. Williams on November 14, 2024
UCSF and University of Washington researchers developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted UCSF Treats First Patient with Homegrown Chimeric Antigen Receptor (CAR) T-cell Therapy
By Cammie Edwards on June 14, 2024
This month marked an important milestone for UCSF faculty and clinicians working to take on the challenge of glioblastoma multiforme (GBM). They treated their first patient with a promising chimeric antigen receptor (CAR) T-cell therapy that was fully conceived, designed, optimized and manufactured... UCSF Scientists Build a Molecular ‘GPS’ to Guide Cell Therapies
By Levi Gadye on April 01, 2024
Wendell Lim earns $30 million contract from ARPA-H to develop a cellular toolkit for therapies targeting diseases of the brain and lung. New CRISPR Center Brings Hope for Rare and Deadly Genetic Diseases
By Jess Berthold on January 09, 2024
CRISPR collaboration combines expertise from three UC schools to scale treatment for diseases that industry has largely passed by – until now. Wiita Team Identifies a Novel Target for Acute Myeloid Leukemia
By Karen Gehrman on November 14, 2023
While immunotherapy has been successful for a number of aggressive cancers, acute myeloid leukemia (AML), a hematologic malignancy with dismal outcomes, has no currently known immunotherapy targets. CRISPR Cures for Cancer: Partnership to Accelerate Cell Therapy Using Genomics
By Karen Gehrman on September 23, 2023
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
By Laura Kurtzman on March 07, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP... Can Lab-Grown Beta Cells Revolutionize Diabetes Care?
By Sarah C. P. Williams on February 08, 2023
In high school, one of Julie Sneddon’s best friends had type 1 diabetes. Like the nearly one and a half million other Americans with the disease, her friend’s pancreas no longer made insulin – a hormone that regulates sugar levels in the body. Sneddon, PhD, now a UC San Francisco assistant... The Long Road to Gene Therapy for Immunodeficient Children
January 11, 2023
Thanks to nearly 30 years of research and effort, another groundbreaking discovery has improved treatment for one of the most devastating genetic disorders affecting young children today.